Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOLA for Ammonia Reduction Post-TIPS
NCT01440829Phase 3Completed
- Sponsor
- Air Force Medical University
- Start
- Dec 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of l-ornithine l-aspartate in hepatic encephalopathy (HE), sponsored by Air Force Medical University. Started Dec 2011; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01440829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440829.